Still, many in the performance and injury rehab communities use BPC-157 off-label for: Chronic tendinopathies Joint degeneration Gut permeability Accelerated post-surgery rehab "Despite limited clinical trials, the number of consistent anecdotal reports and supporting animal research is what drives interest in BPC-157," notes Irrgang and colleagues, Orthopaedic Journal of Sports Medicine
10.1038/s41598-018-25516-3 173 StevenS.FrenisK.OelzeM.KalinovicS.KunticM.Bayo JimenezM
Interestingly, the STEP-8 study 22 revealed a higher incidence of psychiatric events with liraglutide 3 mg (15.0%) compared to semaglutide 2.4 mg (5.6%) and placebo (10.6%)
If there was a discrepancy between authors, the lead author (J.W.) reviewed the article for final study eligibility
These may include nutritional counseling, personal training, body contouring treatments, hormone optimization, and stress management therapies